MedTrace Logo

Combined EDOF / Trifocal

NCT05462067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2022-07-18

No results posted yet for this study

Summary

The purpose of this study is to obtain postoperative visual performance data of patients with bilateral implantation of the AT LARA IOL or the AT LARA implanted in the dominant eye and AT LISA tri implanted in the other eye. Dependence on spectacles, the occurrence of photic phenomena and patient and surgeon satisfaction with the patient's visual performance will be documented. Furthermore, the refraction data will be used to optimize the IOL constants for IOL power calculations.

Conditions

  • Cataract

Interventions

DEVICE

AT LARA IOL

EDOF IOL for treatment of cataract

DEVICE

AT LISA Tri IOL

Trifocal IOL for treatment of cataract

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Principal Investigators

  • Florian Kretz · Augentagesklinik Rheine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2020-11-20
Completion
2020-11-20

Countries

  • Denmark
  • Germany
  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462067 on ClinicalTrials.gov